Clinical Trials Directory

Trials / Completed

CompletedNCT03801486

Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation

The Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation

Status
Completed
Phase
Study type
Observational
Enrollment
34 (actual)
Sponsor
Montclair State University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The investigators examined the effects on post-digestion brachial artery flow mediated dilation (FMD) and in vitro antioxidant capacity of 40% semolina flour replacement with sprouted chickpea flour.

Detailed description

The purpose of the current study was to examine in-vitro and in-vivo effects of replacing 40% of semolina flour with sprouted chickpea flour for the use in pasta. Antioxidant capacity in-vitro was measured by Trolox Equivalent Antioxidant Capacity. Brachial artery flow-mediated dilation, a test of in-vivo endothelial function, was performed for assessment of effects on post-digestion endothelial function. The investigators hypothesized that FMD would be higher after consuming 40% of semolina flour with sprouted chickpea flour pasta vs. 100% of semolina flour pasta.

Conditions

Interventions

TypeNameDescription
OTHERExperimental: Sprouted Chickpea Flour255g of pasta with 40% sprouted chickpea flour and 60% semolina flour (SCF40) with butter.
OTHERControl: Semolina Flour255g of pasta with 100% semolina flour (SEM100) with butter.

Timeline

Start date
2016-03-02
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2019-01-11
Last updated
2023-10-30

Source: ClinicalTrials.gov record NCT03801486. Inclusion in this directory is not an endorsement.